Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr 1;203(7):926-927.
doi: 10.1164/rccm.202012-4328LE.

Mortality in ETHOS: A Question of "Power"

Paola Rogliani  1 , Luigino Calzetta  2
Affiliations
Comment

Mortality in ETHOS: A Question of "Power"

Paola Rogliani et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C, et al. ETHOS Investigators. Reduced all-cause mortality in the ETHOS trial of budesonide/glycopyrrolate/formoterol for COPD: a randomized, double-blind, multicenter parallel-group study. Am J Respir Crit Care Med. [online ahead of print] 30 Nov 2020; DOI: 10.1164/rccm.202006-2618OC. - PubMed
    1. Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, et al. ETHOS Investigators. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383:35–48. - PubMed
    1. Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009;124:471–474. - PMC - PubMed
    1. Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. - PubMed
    1. Scichilone N, Basile M, Battaglia S, Bellia V. What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? Respiration. 2014;87:11–17. - PubMed